Henry Schein (NASDAQ:HSIC – Get Free Report) had its price target upped by investment analysts at Evercore ISI from $83.00 to $90.00 in a research note issued on Wednesday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Evercore ISI’s target price would indicate a potential upside of 25.68% from the company’s current price.
Other equities research analysts have also recently issued research reports about the stock. UBS Group dropped their target price on shares of Henry Schein from $75.00 to $70.00 and set a “neutral” rating on the stock in a report on Wednesday, August 6th. JPMorgan Chase & Co. dropped their price target on Henry Schein from $80.00 to $76.00 and set an “overweight” rating on the stock in a research note on Thursday, August 7th. Leerink Partners set a $75.00 price objective on Henry Schein in a report on Monday, July 14th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Henry Schein in a research report on Friday, October 31st. Finally, Robert W. Baird reissued a “neutral” rating and issued a $72.00 target price (down from $82.00) on shares of Henry Schein in a research report on Monday, July 14th. Five analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $77.25.
View Our Latest Research Report on HSIC
Henry Schein Price Performance
Henry Schein (NASDAQ:HSIC – Get Free Report) last posted its earnings results on Tuesday, November 4th. The company reported $1.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.27 by $0.11. Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The business had revenue of $3.34 billion for the quarter, compared to analysts’ expectations of $3.28 billion. Henry Schein has set its FY 2025 guidance at 4.880-4.960 EPS. On average, sell-side analysts forecast that Henry Schein will post 4.74 EPS for the current year.
Institutional Trading of Henry Schein
Several hedge funds have recently bought and sold shares of HSIC. Alliancebernstein L.P. boosted its holdings in Henry Schein by 21.9% in the 1st quarter. Alliancebernstein L.P. now owns 218,340 shares of the company’s stock worth $14,954,000 after buying an additional 39,188 shares during the period. Great Lakes Advisors LLC bought a new stake in Henry Schein during the first quarter valued at about $4,477,000. Swedbank AB lifted its position in shares of Henry Schein by 30.9% in the second quarter. Swedbank AB now owns 1,156,398 shares of the company’s stock valued at $84,475,000 after acquiring an additional 272,913 shares in the last quarter. Zuckerman Investment Group LLC boosted its stake in shares of Henry Schein by 69.6% in the first quarter. Zuckerman Investment Group LLC now owns 201,639 shares of the company’s stock worth $13,810,000 after acquiring an additional 82,779 shares during the period. Finally, Wellington Management Group LLP boosted its stake in shares of Henry Schein by 15.9% in the first quarter. Wellington Management Group LLP now owns 7,996 shares of the company’s stock worth $548,000 after acquiring an additional 1,094 shares during the period. Institutional investors own 96.62% of the company’s stock.
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
See Also
- Five stocks we like better than Henry Schein
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- 3 Reasons Tesla Could Be a $500 Stock by the End of the Month
- There Are Different Types of Stock To Invest In
- Affirm’s New York Life Deal: A Game-Changing Stamp of Approval
- The Role Economic Reports Play in a Successful Investment Strategy
- 3 Potential Scenarios to Watch for in D-Wave’s Earnings Report
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.
